Sort
23,748 grants matching “melanoma”
Anti-tumor immunity and intestinal microbiota are modulated by mitochondrial DNA
$621,794Douglas C Wallace · Children'S Hosp Of Philadelphia · R01 · FY2023 · CA
Harnessing the power of genetic relatedness for disease gene discovery
$621,762Jennifer Below · Vanderbilt University Medical Center · R01 · FY2020 · GM
Resistance mechanisms to autophagy-modulating therapies
$621,660Ravi K Amaravadi · University Of Pennsylvania · R01 · FY2024 · CA
Combating melanoma with an attenuated bacterial therapeutic
$621,545Jianxun Jim Song · Texas A&M University Health Science Ctr · R01 · FY2023 · CA
O-Glycosylation of Epidermal Growth Factor-like Modules
$621,532Robert S. Haltiwanger · State University New York Stony Brook · R01 · FY2010 · GM
(PQ#3) Novel tumor intrinsic PD-L1 signals direct tumor immune cell infiltration
$621,419Tyler J. Curiel · University Of Texas Hlth Science Center · R01 · FY2019 · CA
Dynamic µOCT for cellular tissue phenotyping
$621,021Guillermo J. Tearney · Massachusetts General Hospital · R01 · FY2025 · CA
A Phase 1 Clinical Trial Evaluating the Novel Small Molecule Immuno-Oncology Antagonist SX-682 Alone and With Pembrolizumab in Metastatic Melanoma
$621,000Stuart J Kahn · Syntrix Biosystems, Inc. · R44 · FY2017 · CA
Environmental chemicals impair epigenetic suppression of the endogenous retrovirus HML-2 in human primordial germ cells, predisposing the next generation to malignancies through HML-2 reactivation
$620,940Toshihiro Shioda · Massachusetts General Hospital · R01 · FY2024 · ES
Basic applications for total-body PET in oncology
$620,929Lorenzo Nardo · University Of California At Davis · R01 · FY2020 · CA
Toward translation of a plant virus-based in situ vaccination nanotechnology
$620,922Nicole Franziska Steinmetz · University Of California, San Diego · R01 · FY2025 · CA
IDENTIFICATION OF MELANOMA PREDISPOSITION LOCI
$620,911University Of Utah · R01 · FY2005 · CA
Impact of Melanoma Genetic Testing on Health Cognitions and Prevention Behaviors
$620,883Sancy Ann Leachman · University Of Utah · R01 · FY2011 · CA
(8) Genomic determinants of the T-cell regulome in immune checkpoint blockade
$620,860Tomas Kirchhoff · New York University School Of Medicine · R01 · FY2018 · CA
Investigating CREB5-driven mechanisms of immune therapy resistance
$620,820Robert Thomas Manguso · Massachusetts General Hospital · R01 · FY2025 · CA
Bladder cancer PD-L1 control of homologous recombination: Basic mechanisms applied to novel treatments
$620,740Tyler J. Curiel · Dartmouth-Hitchcock Clinic · R01 · FY2023 · CA
MODELING NEOANTIGEN AND TCR DYNAMICS IN MELANOMA AND ITS ROLE IN ACQUIRED RESISTANCE TO IMMUNOTHERAPY USING AUTOLOGOUS THYMUS-BEARING HUMANIZED MICE
$620,599The Regents Of The University Of Colorado · · FY2018 · Department of the Army
ENHANCED DEVELOPMENT OF THE XIPHOPHORUS MODEL SYSTEM
$620,365Ronald Walter · Texas State University · R24 · FY2014 · OD
The Nodal Signaling Pathway In Embryonic Development
$620,224Michael Kuehn · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Genetic Epidemiology of Melanoma (GenoMel)
$620,208Peter A Kanetsky · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2014 · CA
New tools for tracking single cells in vivo
$620,088Guillem Pratx · Stanford University · R01 · FY2021 · EB
CAREER: Modulating Local Tumor Hypoxia using Cryogel Scaffolds to Regulate Dendritic Cell Function and Activity
$620,046Sidi A Bencherif · Northeastern University · · FY2019 · MPS
(PQ1) Lipid Metabolism, Inflammation, and T cell Dysfunction in HIV-associated Cancer
$619,967Brinda Emu · Yale University · R01 · FY2020 · CA
Handheld Spatial Frequency Domain Imaging using Spiral Illumination for Skin Imaging
$619,926Darren Michael Roblyer · Boston University (Charles River Campus) · R01 · FY2025 · EB
Dynamic µOCT for cellular tissue phenotyping
$619,861Guillermo J. Tearney · Massachusetts General Hospital · R01 · FY2021 · CA